Biomarker qualification via public-private partnerships

Keyphrases

• Public-private Partnership 100%
• Biomarker Qualification 100%
• Adiponectin 50%
• Patient Outcomes 50%
• Pharmaceutical Companies 50%
• Drug Development 50%
• Randomized Clinical Trial 50%
• Diabetic Patients 50%
• Glycemic Control 50%
• Clinical Pharmacology 50%
• Peroxisome Proliferator-activated Receptor Agonists 50%
• Early Predictors 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Biological Marker 100%
• Drug Development 20%
• Adiponectin 20%
• Randomized Clinical Trial 20%
• Diabetes Mellitus 20%
• PPAR Agonist 20%
• Clinical Pharmacology 20%